PCM
SURF

Penserra Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Penserra Capital Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,040
Closed -$7K – 1609
2021
Q3 		$7K Buy
1,040
+50
+5% +$320 ﹤0.01% 1396
2021
Q2 		$7K Buy
990
+60
+6% +$462 ﹤0.01% 1304
2021
Q1 		$7K Sell
930
-35
-4% -$350 ﹤0.01% 1068
2020
Q4 		$8K Buy
+965
New +$8.39K ﹤0.01% 955

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Penserra Capital Management's SURF Position: Q4 2021 in Review

Penserra Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2021, closing a stake of 1,040 shares — an estimated $7K sold.

Penserra Capital Management first reported a position in SURF in Q4 2020 and held it in 4 quarters. The position peaked at $8K in Q4 2020. 106 funds tracked by Wall St. Rank hold SURF as of Q4 2021.

  • Penserra Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,040 Surface Oncology, Inc. Common Stock shares in Q4 2021, an estimated $7K.
  • Penserra Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's Surface Oncology, Inc. Common Stock position peaked at $8K in Q4 2020.
  • 106 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.